Copyright
©The Author(s) 2025.
World J Clin Oncol. Oct 24, 2025; 16(10): 109385
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.109385
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.109385
Figure 1 Circulating levels of inflammatory biomarkers in the pathogenesis of pancreatic cancer.
Designed by the authors with the help of articles which are already cited in the references, (↑) increased levels (↓) decreased levels, (↨) not sure, (?) Not determined yet.
Figure 2 Haptoglobin causes pathogenesis in pancreatic cancer.
Designed by the authors with the help of articles which are already cited in the references, haptoglobin phenotypes. Hp or Hpt: Haptoglobin.
Figure 3 Serum amyloid A causes pathogenesis in pancreatic cancer.
Designed by the authors with the help of articles which are already cited in the references. SAA: Serum amyloid A; PDAC: Pancreatic ductal adenocarcinoma; CAFs: Cancer-associated fibroblasts; MAGUK: Membrane-associated guanylate kinase.
Figure 4 Fibrinogen causes pathogenesis in pancreatic cancer.
Designed by the authors with the help of articles which are already cited in the references, pancreatic cancer. PC: Pancreatic cancer; Fbg/PNI: Fibrinogen to prognostic nutritional index.
- Citation: Aslam A, Hamid H, Fatima E, Pervaiz S, Arif M, Irshad H, Shafqat A, Khan S, Khurshid H, Rafaqat S. Inflammatory biomarkers in the pathogenesis of pancreatic cancer: A literature review. World J Clin Oncol 2025; 16(10): 109385
- URL: https://www.wjgnet.com/2218-4333/full/v16/i10/109385.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i10.109385